Carlos Millan, MD
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,807 of the $6,674 with a category attached, or 87.0%. 12 manufacturers reported payments, led by UCB, Inc. at 29.1% of the total. 2025 is the largest year on record at $2,689, 2.1 times the $1,264 reported in 2022.
Across 111 payments — averaging $60.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$2K
- Neuropace, Inc.$1K
- Jazz Pharmaceuticals Inc.$925
- Livanova USA, Inc.$816
- Neurelis, Inc.$606
- AbbVie$392
- plus $572 from 6 others
What the payments were for
- Travel & lodging$86713%
- Food & beverage$5,80787%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 34 | $1,939 |
| Neuropace, Inc. | 8 | $1,423 |
| Jazz Pharmaceuticals Inc. | 14 | $925 |
| Livanova USA, Inc. | 15 | $816 |
| Neurelis, Inc. | 13 | $606 |
| AbbVie | 12 | $392 |
| SK Life Science, Inc. | 7 | $300 |
| Ceribell, Inc. | 1 | $120 |
| Pfizer | 3 | $67 |
| AstraZeneca | 2 | $43 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $23 |
| Lundbeck LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RNS Neurostimulator Kit$1,317
- Epidiolex$528
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$508
- Briviact$372
- VALTOCO$267
- Fintepla$257
- XCOPRI$125
- Ceribell Rapid Response EEG$120
- UBRELVY$115
How this compares
$6,674 in reported general payments places this provider in the 55th percentile of 23 epilepsy providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other epilepsy in Miami
- Andrew LermanMiami$249K
- Alberto Pinzon ArdilaMiami$144K
- Miguel Melo-BicchiMiami$15K
- Luis TornesMiami$6K
- Gisela Moreira EyngMiami$3K
- Brian CostellBoca Raton$469K
- Jaivir RathoreOrlando$38K
- Dipali NemadeOrlando$38K
- Mohamed NasserWeston$28K
- William TatumJacksonville$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.